These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11291881)

  • 1. Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations.
    Yang YY; Lin HC; Lee WC; Hou MC; Lee FY; Chang FY; Lee SD
    J Gastroenterol; 2001 Mar; 36(3):181-6. PubMed ID: 11291881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
    Reymond M; Barbier L; Salame E; Besh C; Dumortier J; Pageaux GP; Bureau C; Dharancy S; Vanlemmens C; Abergel A; Woehl Jaegle ML; Magro P; Patat F; Laurent E; Perarnau JM
    Transplantation; 2018 Apr; 102(4):616-622. PubMed ID: 29077657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portopulmonary hypertension.
    Mukhtar NA; Fix OK
    J Clin Gastroenterol; 2011 Sep; 45(8):703-10. PubMed ID: 21325952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of portopulmonary hypertension: new perspectives.
    Mancuso L; Scordato F; Pieri M; Valerio E; Mancuso A
    World J Gastroenterol; 2013 Dec; 19(45):8252-7. PubMed ID: 24363516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
    Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary complications of hepatic cirrhosis: portopulmonary hypertension and hepatopulmonary syndrome. The paradox of pulmonary vasoconstriction and vasodilation].
    Chávez-Tapia NC; Uribe M; López E
    Gac Med Mex; 2007; 143(4):333-9. PubMed ID: 17969842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary hypertension complicating portal hypertension: portopulmonary hypertension].
    Katsuta Y; Zhang XJ; Aramaki T
    Nihon Rinsho; 2001 Jun; 59(6):1186-92. PubMed ID: 11411134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-receptor antagonist treatment of portopulmonary hypertension.
    Hinterhuber L; Graziadei IW; Kähler CM; Jaschke W; Vogel W
    Clin Gastroenterol Hepatol; 2004 Nov; 2(11):1039-42. PubMed ID: 15551258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel use of sildenafil in the treatment of portopulmonary hypertension.
    Chua R; Keogh A; Miyashita M
    J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portopulmonary hypertension in liver transplant candidates.
    Bozbas SS; Bozbas H
    World J Gastroenterol; 2016 Feb; 22(6):2024-9. PubMed ID: 26877607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
    Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
    Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension.
    Legros L; Chabanne C; Camus C; Fournet M; Houssel-Debry P; Latournerie M; Jezequel C; Rayar M; Boudjema K; Guyader D; Bardou-Jacquet E
    Dig Liver Dis; 2017 Mar; 49(3):301-307. PubMed ID: 27840058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary complications in cirrhosis.
    Sussman NL; Kochar R; Fallon MB
    Curr Opin Organ Transplant; 2011 Jun; 16(3):281-8. PubMed ID: 21543981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secure Combination Therapy With Low-Dose Bosentan and Ambrisentan to Treat Portopulmonary Hypertension Minimizing Each Adverse Effect.
    Muraoka H; Imamura T; Hatano M; Maki H; Yao A; Kinugawa K; Komuro I
    Int Heart J; 2015; 56(4):471-3. PubMed ID: 26084462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension.
    Wang YW; Lin HC; Yang YY; Hou MC; Lee SD
    J Gastroenterol; 2006 Jun; 41(6):593-7. PubMed ID: 16868809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension.
    Chiva T; Ripoll C; Sarnago F; Rincón D; Gómez-Camarero J; Galindo E; Catalina MV; Elizaga J; Bañares R
    Liver Int; 2015 Feb; 35(2):353-61. PubMed ID: 24797536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portopulmonary hypertension and serum endothelin levels in hospitalized patients with cirrhosis.
    Tsiakalos A; Hatzis G; Moyssakis I; Karatzaferis A; Ziakas PD; Tzelepis GE
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):393-8. PubMed ID: 21813388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane-dependent portopulmonary hypertension.
    Maruyama T; Ohsaki K; Shimoda S; Kaji Y; Harada M
    Am J Med; 2005 Jan; 118(1):93-4. PubMed ID: 15639216
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
    Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.